Trials / Sponsors / Attgeno AB
Attgeno AB
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hyperten Pulmonary Hypertension | Phase 2 | 2022-10-23 |
| Withdrawn | A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pul Pulmonary Hypertension, COVID-19 | Phase 1 / Phase 2 | 2021-05-07 |
| Completed | A First-in-Human Study to Assess the Safety and Tolerability of PDNO Pulmonary Hypertension | Phase 1 | 2021-02-02 |
| Completed | The Prevalence of Pulmonary Hypertension in Patients With COVID-19. Hypertension, Pulmonary, Right Ventricular Overload, COVID | — | 2020-06-01 |